The following represents disclosure information provided by authors of this abstract. The program committee has reviewed all presenting author disclosure reports, identified potential conflicts of interest, and implemented strategies to manage those areas of conflict, where appropriate. All relationships are considered compensated. Relationships are self-held unless otherwise noted. I = Immediate Family Member, Inst = My Institution
 
Open Payments is a public database containing information reported by companies about payments made to US-licensed physicians (Open Payments)
 
 
Research Funding - BeiGene
Travel, Accommodations, Expenses - BeiGene

Tislelizumab plus cisplatin/carboplatin and gemcitabine versus placebo plus cisplatin/carboplatin and gemcitabine in Chinese patients with advanced urothelial carcinoma: A phase III trial in progress.
 
Feng BI
No Relationships to Disclose
 
Han-Zhong Li
No Relationships to Disclose
 
Shaoxing Zhu
No Relationships to Disclose
 
Qing Zou
No Relationships to Disclose
 
Jia Tang
Employment - BeiGene
 
Wei Zhang
Employment - BeiGene
 
Dingwei Ye
No Relationships to Disclose